Nucana presents promising data on nuc-7738 at the aacr-nci-eortc international conference on molecular targets and cancer therapeutics 2023

Data from the nutide:701 study indicate nuc-7738 may potentiate the activity of anti-pd-1 agents in patients who were refractory to or progressed on prior immunotherapy, including anti-pd-1 therapy

NCNA Ratings Summary

NCNA Quant Ranking